The global gastrointestinal bleeding treatment market is set to expand moderately at a CAGR of 5.1% between 2020 and 2026, attributed to preference for endoscopic hemostasis to correct GI problems. Gastrointestinal problems, particularly upper gastrointestinal bleeding (UGIB), are becoming more prevalent across the world. Itsource https://www.openpr.com/news/2241110/gastrointestinal-bleeding-treatment-market-projected